CXCL1 and neoplasm: Therefore, the ability of DEX to suppress IL-8, CXCL1 and VEGF would appear to underpin an enhanced suppression of the tumour vasculature in the PC3 model of CRPC and potentiate the antiangiogenic effect of docetaxel.